AVBP•benzinga•
Jones Trading Initiates Coverage On ArriVent BioPharma with Buy Rating, Announces Price Target of $40
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 20, 2025 by benzinga